AZ bullish on its future – but analysts wary
January 15, 2014Sales and Marketing AstraZeneca, Roche, analysts, jp morgan
AstraZeneca is combating fears over its long-term future by assuring investors that it has the pipeline and the tenacity to …
ICON hires Dr Steve Cutler as chief operating officer
January 15, 2014Manufacturing and Production, Research and Development, Sales and Marketing ICON, cutler
Clinical research organisation ICON has appointed Dr Steve Cutler to the newly created position of chief operating officer (COO).
UK cancer figures rise
January 15, 2014Research and Development, Sales and Marketing Cancer, England, NHS, research uk
More people are being diagnosed with cancer than ever before, according to figures from Cancer Research UK – as an …
Bayer and Regeneron to co-develop wet AMD antibody
January 14, 2014Research and Development, Sales and Marketing Bayer, Eylea, Regeneron, pdgfr-beta, wet AMD
Bayer and Regeneron are co-developing an antibody to the Platelet Derived Growth Factor Receptor Beta (PDGFR-beta) as a combination therapy …
FDA approves GSK cancer combo
January 14, 2014Research and Development, Sales and Marketing FDA, GSK, Tafinlar, mekinist
US regulators have shown the green light to a combination of two GlaxoSmithKline skin cancer drugs, Mekinist and Tafinlar, to …
Sanofi signs new genetics deal with Isarna
January 14, 2014Manufacturing and Production, Research and Development, Sales and Marketing DNA, RNA, Sanofi, aso, isarna
Sanofi has agreed to produce genetic compounds developed by German biotech Isarna Therepeutics to accelerate their progress to the clinical …
Incyte names former Novartis president as its chief executive
January 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Incyte, Novartis, hoppenot
Biopharma firm Incyte has announced that the former president of Novartis Oncology has been named as its president and chief …
GSK makes imaging deal
January 14, 2014Manufacturing and Production, Sales and Marketing 3D, GSK, imaging, npl
GlaxoSmithKline has signed a deal with the National Physical Laboratory (NPL) to develop an imaging system which can show for …
New managing director for Boehringer Ingelheim UK
January 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, krumins
Zinta Krumins has been appointed as the managing director of Boehringer Ingelheim UK & Ireland. The appointment will present a …
NICE: Daily Mail ‘misled’ readers
January 13, 2014Sales and Marketing Dillon, NHS, NICE, mail
UK drugs watchdog NICE has hit back at an article in the Daily Mail headlined “Champagne perks of NHS drug …
Sanofi pays $700m to expand rare disease portfolio
January 13, 2014Research and Development, Sales and Marketing Alnylam, Sanofi, rare sidease
Sanofi and Alnylam have announced the expansion of their 2012 agreement to develop and sell treatments for rare genetic diseases. …
Thought leader mapping: do we need a radical rethink?
January 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Havas, bartley, marketing, sales, thought leader
The effectiveness of healthcare communications is often more reliant on who’s delivering the message than the content of the message …
New chief executive for Quanta Fluid Solutions
January 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing milad, quanta
Medical devices firm Quanta Fluid Solutions has announced the appointment of John Milad as chief executive. Milad’s career spans 20 …
Treat patients ‘more holistically’
January 13, 2014Sales and Marketing Hunt, Mid Staffs, NHS, new year
UK health secretary Jeremy Hunt has spoken of the challenges faced by the NHS in a New Year message to …
FDA approves Farxiga
January 10, 2014Sales and Marketing AstraZeneca, BMS, FDA, Forxiga, diabetes
The FDA has approved Farxiga, the diabetes treatment developed by AstraZeneca and Bristol-Myers Squibb as part of their soon-to-be-defunct diabetes …
Chris Kilbee appointed Group director of UBM Pharma Portfolio


January 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPhI, UBM pharma, amsterdam
Amsterdam: CPhI, part of UBM Live, has announced the appointment of Chris Kilbee to the role of Group director of …
UK cancer death rate could be halved by 2030
January 10, 2014Research and Development, Sales and Marketing Cancer, Taylor, UCL, wardle
British cancer deaths could drop 50% by 2030 if early diagnosis and improved treatment policies are put in place academics …
World’s first Alzheimer’s vaccine trial begins
January 10, 2014Research and Development, Sales and Marketing AC Immune, ACI-35, Alzheimer's, Vaccine
AC Immune, a privately-held biotech based in Switzerland, has launched the world’s first trial of a vaccine against a protein …
Merck Serono hires global chief medical officer
January 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Serono, hildemann
Merck Serono has appointed Steven Hildemann as global chief medical officer and head of its global Medical and Safety unit. …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
